10x Genomics Inc - Ordinary Shares - Class A
TXG
Market Cap$1.08B
Close$
$42.06
357.1% upside
Current Fair Value
357.1% upsideUndervalued by 357.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.08 Billion |
|---|---|
| Enterprise Value | $840.21 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.52 |
| Beta | 1.94 |
| Outstanding Shares | 121,596,351 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.84 |
|---|---|
| PEG | 9.49 |
| Price to Sales | 1.84 |
| Price to Book Ratio | 1.84 |
| Enterprise Value to Revenue | 1.33 |
| Enterprise Value to EBIT | -4.45 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About 10x Genomics Inc
CEO: Serge Saxonov